Methods of assessment of pre-clinical alzheimer's disease
CA3327622A1Undetermined Publication Date: 2025-10-23THE GENERAL HOSPITAL CORP +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3327622
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-15
- Filing Date
- 2025-04-15
- Publication Date
- 2025-10-23
Abstract
Described herein are methods of assessing the risk of dementia in a subject using an odor-based test, or "smell test". These methods can be self-administered by the subject under the instruction of a computing device via a user interface. Methods of administering a smell test as described herein can optionally be combined with measuring and quantifying the level of at least one biomarker for dementia (e.g., CXCL10, CCL2, IL-6) in a biological sample collected from the subject. Also provided are methods to treat dementia (e.g., dementia associated with Alzheimer's disease, dementia associated with a subset of Alzheimer's disease patients with TDP-43 pathology).
Need to check novelty before this filing date? Find Prior Art
